𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1108-121 Survival benefit with spironolactone therapy is not related to reduced hsCRP levels in severe congestive heart failure: Results from a RALES substudy

✍ Scribed by Michel F Rousseau; Annie R Robert; Ronald Van Beneden; Birginie de Coninck; Sylvie A Ahn; Jean-Marie Ketelslegers; Hubert G Pouleur


Book ID
119548657
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
334 KB
Volume
43
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.